NIIMBL receives $83M to tackle vaccine development
Share
NEWARK – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) was recently awarded $153 million in new funding from its federal partners, including $83 million specifically to work on coronavirus-related projects. “Obviously, there's an element of COVID-19, but also a big part of it is how we make sure we never have this happen
Want to Read More?
Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.
Already an Insider? Log In.